This episode of Industry Focus is brought to you by Sinios Health, a new fully integrated

bio-pharmaceutical solutions organization that's the result of a merger between

Inc research and inventive health. Sinios Health is focused on a simple end goal shortening the distance from lab to life.

To learn more, visit sinios Health.com.

podcast.

Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day.

Today is June 20th and this is the Wednesday Healthcare Edition of the show.

I'm your host Christine Harjus and I'm joined by health care specialist Todd

Campbell via Skype. Today is going to be one of those news news news shows

where we take you through some of the most exciting developments in the

health care space from the last week or so.

First up, Todd's going to take a victory lap for pitching Foundation Medicine, ticker

FMI, as his top health care stock to buy last October.

The stock is up 229% since then. A high water market hit

after the announcement on Tuesday of this week that Roche is buying the company

or rather the part of the company that it doesn't already own. So Todd

congratulations on a stellar pick. I hope you had put your money where your

mouth was. I did Christine, I did so of course you know I'm smiling but for every victory there's always going to be one that is no victory right so you know you got to be humble when it comes to this kind of stuff

but yeah you know big news for investors and owners of this company

and potentially for people who are making bets

in personalized medicine.

You know, I think that anybody who wants to learn more about Foundation Medicine

...